Tai Chi Mind-Body Therapy for Chronic Heart Failure
- Conditions
- Heart Failure
- Interventions
- Behavioral: 12-week Tai Chi ProgramBehavioral: 12-week Education Program
- Registration Number
- NCT00110227
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Brief Summary
The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure (HF). This study will also examine the way tai chi influences mental, physical, and social functioning.
- Detailed Description
HF is a major public health problem in the United States, affecting approximately 5 million adults. Despite recent advances in pharmacologic therapy and technologic devices, HF is the most common reason for hospitalization among Medicare patients and is reaching epidemic proportions as the population ages. New and inexpensive interventions that can improve functional capacity and quality of life and can delay disease progression are needed. Tai chi is a popular mind-body exercise that is a potential treatment for heart disease. This exercise incorporates both gentle physical activity and meditation, and it may be particularly suited to frail patients with HF. This study will examine the effects of a tailored tai chi program on functional capacity and quality of life in patients with HF.
Participants will be randomly assigned to either a tai chi program or heart health education for 12 weeks. Participants in both groups will undergo a bicycle stress test at study entry and will receive weekly training sessions of their assigned intervention. Self-report scales and questionnaires will be used to assess participants at study start and at the end of 12 weeks.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Diagnosis of chronic HF
- Percentage of blood pumped from the left ventricle (ventricular ejection fraction) less than 40% for at least 1 year prior to study entry
- Stable medical regimen, defined as no major changes in medication, in the 3 months prior to study entry
- New York Heart Association Classification of Class I (no activity limitations), Class II (slight activity limitations), or Class III (marked activity limitations)
- English-speaking
- Unstable angina, myocardial infarction, cardiac resynchronization, or major cardiac surgery within 3 months prior to study entry
- History of cardiac arrest or diagnosis of peripartum cardiomyopathy within 6 months prior to study entry
- Unstable ventricular arrhythmias or structural valvular disease
- Current participation in a conventional cardiac rehabilitation program
- Inability to perform a bicycle stress test at study entry
- Lower extremity amputation or other inability to walk due to conditions other than HF
- Severe cognitive dysfunction preventing informed consent and understanding of tai chi concept
- Current regular practice of tai chi
- Current participation in a tai chi pilot study or other studies
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Tai Chi 12-week Tai Chi Program 12-week tai chi program Heart Health Education 12-week Education Program 12-week attention control
- Primary Outcome Measures
Name Time Method HF-specific quality of life baseline, midpoint, endpoint, 6mo functional capacity baseline and endpoint Walking Test baseline, midpoint, endpoint
- Secondary Outcome Measures
Name Time Method echocardiography baseline and endpoint General quality of life baseline, midpoint, endpoint, 6mo mood and emotional status baseline, midpoint, endpoint, 6mo exercise self-efficacy baseline, midpoint, endpoint, 6mo sense of coherence baseline, midpoint, endpoint, 6mo utility assessment baseline, midpoint, endpoint, 6mo beliefs, attitudes, and expectations baseline, midpoint, endpoint physical activity level baseline, midpoint, endpoint perceived social support baseline, midpoint, endpoint neurohormonal status baseline, midpoint, endpoint autonomic tone, heart rate variability baseline and endpoint costs and use of HF services baseline and endpoint
Trial Locations
- Locations (4)
Lown Cardiovascular Center
🇺🇸Brookline, Massachusetts, United States
Brigham and Women's Hospital
🇺🇸Boston, Massachusetts, United States
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center, Harvard Medical School
🇺🇸Boston, Massachusetts, United States